semaglutide fact sheet Wegovy® receives FDA approval for cardiovascular risk reduction in adults Is Semaglutide Right for You?
Description
A 55-year-old woman with obesity, type 2 diabetes, and a history of small bowel obstruction developed severe abdominal pain and nausea after starting semaglutide

Other anti-androgenic medications include flutamide and finasteride

Results Reducing dose frequency does not commensurately reduce weight loss

The boring, slow, expensive infrastructure of behavioral neuroscience

Alternate the injection site between the stomach, thigh, and upper arm with each injection

I also highlighted #OCW2025 obesity care week and World Obesity Day March 4th to bring awareness to the need for all Americans and people throughout the world to have access to non-stigmatizing unbiased comprehensive care
